Hydroxy urea RLD selection for EMA submission [Regulatives / Guidelines]

posted by Praful Rane – India, 2025-07-29 13:08 (309 d 20:07 ago) – Posting: # 24420
Views: 3,188

Dar All,

We are requesting for scientific advice on selection of RLD.

We are under development of drug product Hydroxyurea Oral Suspension for Europe Market.
As a part of our development program, we would like to seek your guidance on the selection of RLD for bioequivalence (BE) studies of Hydroxyurea Oral Suspension drug product. Specifically, we would like to request your technical advice for choice of RLD to be considered for the comparative BE i.e. RLD dosage form like Tablet, Capsules & Oral Solution to conduct the BE studies for our drug product which is oral suspension.

For your more information, we would like to let you know that we have been already procured Oral Solution as RLD and require your expert advice.


waiting for the valuable inputs...

Praful Rane

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
219 visitors (0 registered, 219 guests [including 24 identified bots]).
Forum time: 09:15 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5